Analysis on the Effect and Safety of Baihe Wuyao Xiexin Decoction in Treating Reflux Esophagitis

Hui Wang, Siyan Xu, Yutong Ge, Meijuan Gu, Meng Ye, Panpan LiuAmerican 2025 · DOI

TL;DR

This clinical study demonstrates that a modified Traditional Chinese Medicine (TCM) formula, Baihe Wuyao Xiexin Decoction, outperforms standard Western pharmacological treatments for reflux esophagitis. The herbal decoction achieved a 97.5% total effective rate with significantly fewer adverse side effects (5% vs. 25%) compared to a regimen of Rabeprazole and Domperidone.

What Problem Does This Paper Address?

Reflux esophagitis (RE) is a chronic digestive disorder characterized by the backflow of gastric or duodenal contents into the esophagus, causing inflammation and symptoms like heartburn, acid reflux, and chest pain.

While conventional Western medicine typically relies on Proton Pump Inhibitors (PPIs) to suppress acid and prokinetic drugs to improve motility, these treatments are not universally effective. Many patients experience recurring symptoms or significant side effects, such as diarrhea and nausea. The authors sought to evaluate whether a TCM approach—which focuses on "harmonizing the stomach" and "clearing liver fire"—could provide a more effective and better-tolerated alternative.

Methods

The researchers conducted a randomized controlled trial involving 80 patients diagnosed with RE between 2021 and 2023. The participants were split into two equal groups:

  • Control Group (n=40): Received standard Western treatment consisting of Rabeprazole (an acid suppressor) and Domperidone (a motility stimulant) for one month.
  • Observation Group (n=40): Received the Modified Baihe Wuyao Xiexin Decoction. This herbal "cocktail" included ingredients like Lily (Baihe), Licorice, French Pinellia, Ginseng, and Scutellaria. The dosage was customized based on specific patient symptoms (e.g., adding Dandelion for severe heartburn).

The study used a 0–3 point scoring system to quantify symptoms and employed SPSS 20.0 for statistical validation (t-tests and chi-square tests).

Datasets

The study relied on a primary clinical dataset of 80 patients recruited from a hospital setting.

  • Inclusion Criteria: Clear symptoms of RE and diagnostic confirmation.
  • Exclusion Criteria: Pregnancy, malignant tumors, or severe liver/kidney dysfunction. No external benchmarks or public datasets were utilized; the findings are based entirely on the authors' original clinical observations.

Key Insights and Ideas

  • The "Monarch and Minister" Synergy: The paper details the pharmacological roles of the herbs within TCM theory. Wuyao and Lily act as "monarch" medicines to warm the kidneys and nourish internal organs, while Dried Ginger and Coptis act as "ministerial" drugs to regulate qi and stop vomiting.
  • Holistic vs. Symptomatic Treatment: While Western medicine targets the physical mechanism of acid production, the TCM approach aims to restore the "orderly rise and fall" of the digestive system's energy, addressing what the authors describe as the root cause: disharmony between the liver and stomach.
  • Superior Safety Profile: Perhaps the most significant insight is the disparity in adverse reactions. The TCM group showed a five-fold decrease in side effects compared to the control group, suggesting that the herbal formula is much gentler on the gastrointestinal tract than synthetic PPIs and motility drugs.

Key Results

The quantitative results strongly favored the TCM intervention:

  • Total Effective Rate: The observation group reached 97.5%, significantly higher than the control group's 80.0% ($P < 0.05$).
  • Symptom Reduction: TCM symptom scores for heartburn ($0.89 \pm 0.20$ vs $1.00 \pm 0.25$) and acid reflux ($0.79 \pm 0.17$ vs $0.90 \pm 0.21$) were significantly lower in the herbal group.
  • Adverse Events: The total incidence of side effects was only 5.0% for the herbal decoction, compared to 25.0% for the Western medicine group.

Limitations and Future Work

The authors acknowledge (or the study implies) several limitations:

  • Sample Size: A cohort of 80 patients is relatively small for a clinical trial; larger, multi-center studies would be required to generalize these results.
  • Study Duration: The follow-up period was only one month. Since reflux esophagitis is a chronic, often relapsing condition, long-term data on recurrence rates is missing.
  • Mechanistic Depth: While the paper explains the results through the lens of TCM theory, it does not provide molecular-level data (e.g., changes in esophageal pH or specific inflammatory cytokines) to explain how the herbs achieve these results at a cellular level.

Future research could focus on the long-term stability of these improvements and the potential for integrating these herbal formulas into standard clinical guidelines.

Summary updated

Abstract

To analyze the efficacy and safety of Baihe Wu Yao Xiexin Decoction in the treatment of reflux esophagitis. Methods: A total of 80 patients with reflux esophagitis were selected from June 2021 to June 2023. Patients were randomly divided into a observation group, with 40 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Baihe Wuyao Xiexin Decoction. The therapeutic effect, TCM symptom score and adverse reactions were compared between the two groups. Results: In terms of treatment effect, the total effective rate of observation group was 97.50% higher than that of control group (80.00%), P &lt; 0.05. In terms of TCM symptom score, the observation group had heartburn (0.89±0.20) score, acid reflux (0.79±0.17) score, constipation (0.67±0.14) score, dry mouth and bitter mouth (0.77±0.19) score, emotional distress (0.73±0.13) score, and pain in the two hypochasm (0.84±0.15) score. They were lower than (1.00±0.25) points, (0.90±0.21) points, (0.78±0.17) points, (0.87±0.18) points, (0.83±0.19) points and (0.95±0.23) points in the control group, respectively, P &lt; 0.05. In terms of adverse reactions, the total incidence of 5.00% in the observation group was lower than 25.00% in the control group (P &lt; 0.05). Conclusion: In the treatment of reflux esophagitis, the use of Baihe Wu drug Xiexin decoction can improve the total effective rate, alleviate symptoms, reduce adverse reactions, the effect and safety are very ideal.
BibTeX
@inproceedings{wang2025analysis,
  author = {Hui Wang and Siyan Xu and Yutong Ge and Meijuan Gu and Meng Ye and Panpan Liu},
  title = {{Analysis on the Effect and Safety of Baihe Wuyao Xiexin Decoction in Treating Reflux Esophagitis}},
  booktitle = {American},
  year = {2025},
  doi = {10.54536/ajmsi.v4i1.4142},
}
Figure